RhoBTB2 (DBC2) comes of age as a multifunctional tumor suppressor

Cancer Biology and Therapy

Volumn 10, Issue 11, 2010, Pages 1123-1125

  Freeman, Scott N ^a   Cress, W Douglas ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

BRMS1; DBC2; E2F1; Invasion; Migration; RhoBTB2; Tumor suppressor

Indexed keywords

CYCLIN D1; TRANSCRIPTION FACTOR E2F1;

BREAST CANCER; CANCER CELL; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; HETEROZYGOSITY LOSS; HUMAN; LUNG CANCER; NOTE; RHOBTB2 GENE; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; GTP-BINDING PROTEINS; HUMANS; TUMOR SUPPRESSOR PROTEINS;

EID: 78649900955     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.11.13786     Document Type: Note

References (14)

1. Hamaguchi M, Meth JL, von Klitzing C, Wei W, Esposito D, Rodgers L, et al. DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc Natl Acad Sci 2002; 99:13647-52; PMID: 12370419.
2. Ling L, Lu C, Zhou G, Wang S. Ectopic expression of RhoBTB2 inhibits migration and invasion of human breast cancer samples. Cancer Biol Ther 2010; 10:1115-22.
3. Berthold J, Schenkova K, Rivero F. Rho GTPases of the RhoBTB subfamily and tumorigenesis. Acta Pharmacol Sin 2008; 29:285-95.
4. Beder LB, Gunduz M, Ouchida M, Gunduz E, Sakai A, Fukushima K, et al. Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer. J Cancer Res Clin Oncol 2006; 132:19-27. (Pubitemid 41712802)
5. Shi Y, Chen JY, Yang J, Li B, Chen ZH, Xiao CG. DBC2 gene is silenced by promoter methylation in bladder cancer. Urol Oncol 2008; 26:465-9.
6. Yoshihara T, Collado D, Hamaguchi M. Cyclin D1 downregulation is essential for DBC2's tumor suppressor function. Biochem Biophys Res Commun 2007; 358:1076-9. (Pubitemid 46828997)
7. Siripurapu V, Meth J, Kobayashi N, Hamaguchi M. DBC2 significantly influences cell cycle, apoptosis, cytoskeleton and membrane-trafficking pathways. J Mol Biol 2005; 346:83-9.
8. Freeman SN, Ma Y, Cress WD. RhoBTB2 (DBC2) is a mitotic E2F1 target gene with a novel role in apoptosis. J Biol Chem 2008; 283:2353-62.
9. Collado D, Yoshihara T, Hamaguchi M. DBC2 resistance is achieved by enhancing 26S proteasome-mediated protein degradation. Biochem Biophys Res Commun 2007; 360:600-3. (Pubitemid 47048141)
10. Wilkins A, Ping Q, Carpenter CL. RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex. Genes Dev 2004; 18:856-61. (Pubitemid 38529655)
11. Brambilla D, Fais S. The Janus-faced role of ezrin in "linking" cells to either normal or metastatic phenotype. Int J Cancer 2009; 125:2239-45.
12. Chau NM, Ashcroft M. Akt2: a role in breast cancer metastasis. Breast Cancer Res 2004; 6:55-7. (Pubitemid 38195561)
13. Stanelle J, Stiewe T, Theseling CC, Peter M, Pützer BM. Gene expression changes in response to E2F1 activation. Nucleic Acids Res 2002; 30:1859-67.
14. D'Souza SJ, Vespa A, Murkherjee S, Maher A, Pajak A, Dagnino L. E2F-1 is essential for normal epidermal wound repair. J Biol Chem 2002; 277:10626-32.